535924-73-3 Usage
Uses
Used in Pharmaceutical Industry:
3-Ethoxy-azetidine hydrochloride is used as a precursor in the synthesis of various pharmaceutical compounds due to its unique azetidine ring structure and ethoxy group, which can be manipulated to create novel drugs with specific therapeutic effects.
Used in Neuroscience Research:
In the field of neuroscience, 3-Ethoxy-azetidine hydrochloride is used as a research tool to study the effects of central nervous system depressants. Its potential role in modulating neural activity and behavior makes it valuable for understanding the underlying mechanisms of certain neurological disorders and conditions.
Used in Drug Development:
3-Ethoxy-azetidine hydrochloride is utilized in drug development as a lead compound for the creation of new medications. Its chiral nature allows for the exploration of the different biological activities of its enantiomers, potentially leading to the discovery of more effective and safer drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 535924-73-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,5,9,2 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 535924-73:
(8*5)+(7*3)+(6*5)+(5*9)+(4*2)+(3*4)+(2*7)+(1*3)=173
173 % 10 = 3
So 535924-73-3 is a valid CAS Registry Number.
535924-73-3Relevant academic research and scientific papers
4-OXO-3,4-DIHYDROQUINAZOLINON COMPOUNDS FOR THE TREATMENT OF BRAF-ASSOCIATED DISEASES AND DISORDERS
-
Page/Page column 0260-0261, (2021/12/31)
The invention relates to a compound represented by formula I: or a pharmaceutically acceptable salt thereof, formula wherein R1,R2,R3,R4,R5,R6,R7 and L are as defined in the description, for the treatment of diseases and conditions associated with BRAF, including tumors associated with BRAF.
AZETIDINE-SUBSTITUTED PYRAZOLINES AS PAR-1 ANTAGONISTS
-
Page/Page column 57, (2008/06/13)
The invention relates to blood clotting, and especially to the use of azetidine-substituted pyrazolines as medicaments, novel azetidine-substituted pyrazolines, methods for the production thereof, and the use of the same for producing medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular diseases, preferably thromboembolic diseases.
